Such that breast cancer metastases to the lungs, lymph nodes, and thoracic cavity can be controlled using human-specific anti-CD9 or anti-CD63 antibodies which target CD9/CD63 receptor on the surface of EVs. Here, CD9 is linked to breast carcinoma.